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Abstract
Background: Medication problems among patients with long-term conditions (LTCs) are well documented. Measures to
support LTC management include: medicine optimisation services by community pharmacists such as the Medicine Use
Review (MUR) service in England, implementation of shared decision making (SDM), and the availability of rapid access
clinics in primary care. This study aimed to investigate the experience of patients with LTCs about SDM
including medication counselling and their awareness of community pharmacy medication review services.
Methods: A mixed research method with a purposive sampling strategy to recruit patients was used. The
quantitative phase involved two surveys, each requiring a sample size of 319. The first was related to SDM
experience and the second to medication counselling at discharge. Patients were recruited from medical wards at St.
George’s and Croydon University Hospitals.The qualitative phase involved semi-structured interviews with 18 respiratory
patients attending a community rapid access clinic. Interviews were audio-recorded and transcribed verbatim. Thematic
analysis using inductive/deductive approaches was employed. Survey results were analysed using descriptive statistics.
Results: The response rate for surveys 1 and 2 survey was 79% (n = 357/450) and 68.5% (240/350) respectively. Survey 1
showed that although 70% of patients had changes made to their medications, only 40% were consulted about them
and two-thirds (62.2%) wanted to be involved in SDM. In survey 2, 37.5% of patients thought that medication counselling
could be improved. Most patients (88.8%) were interested in receiving the MUR service; however 83% were not aware of
it. The majority (57.9%) were interested in receiving their discharge medications from community pharmacies. The
interviews generated three themes; lack of patient-centered care and SDM, minimal medication counselling provided
and lack of awareness about the MUR service.
Conclusion: Although patients wanted to take part in SDM, yet SDM and medication counselling are not optimally
provided. Patients were interested in the MUR service; however there was lack of awareness and referral for this service.
The results propose community pharmacy as a new care pathway for medication supply and counselling post discharge.
This promotes a change of health policy whereby community-based services are used to enhance the performance of
acute hospitals.
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Background
Prescription of medications is the most common interven-
tion in healthcare [1, 2]. However, medication problems
occurring during the transition of care/after hospital dis-
charge are well documented in the literature [3–5] and may
lead to patient harm and hospital readmissions [5]. These
difficulties are exacerbated because providers do not
provide sufficient medication information to patients.
The National Outpatient Survey (2011), found that only
43% of patients were confident that healthcare professionals
(HCPs) were counselling them about all side-effects of their
medications, (a decrease from 45% in 2009) [6].
Problems in medication usage are also documented in
primary care especially among patients with long-term
conditions (LTCs) [7]. These have been reported to nega-
tively impact patients’ adherence and safety and lead to in-
creased use of medical resources, such as physician visits,
emergency department visits, hospital admissions and treat-
ment failure [7]. An example of this would be chronic ob-
structive pulmonary disease (COPD), which is a chronic
inflammatory condition that has been well documented in
the literature to pose a high economic burden due to costly
hospital admissions and medication wastage [8, 9]. Further-
more, poor adherence to medications and poor inhalation
technique are widely reported problems among respiratory
patients that lead to sub-optimal management and care,
and increase the economic burden of COPD [9]. Therefore,
some trusts such as Croydon University Hospital in the UK
has established a rapid access clinic, referred to as “the
respiratory HoT clinic” to improve the outcomes for COPD
patients and prevent unnecessary hospital admissions. The
service is managed by Croydon hospital respiratory team
and provides the chance for patients to be seen by a spe-
cialist from secondary care in the primary care setting on
the same day or next day, thus reducing the risk of accident
and emergency visits due to sudden deterioration in their
COPD condition [10].
Other measures to support LTCs management include
medicine optimisation services offered by community
pharmacists across many countries such as UK, United
States, Canada and Australia [11, 12]. In England, cogni-
tive services such as Medicine Use Review (MUR) and
New Medicine Service (NMS) were introduced in the
community pharmacy sector in 2005 and 2011, respectively
as part of the government’s strategy to promote medicine
optimisation and reduce medication wastage for patients
suffering from LTCs [13]. According to the National
Institute for Health and Clinical Excellence (NICE) guide-
lines [14], medicine optimisation requires a patient centred
approach for safe and effective medicines use, in order to
ensure that patients are getting the best possible outcomes
from their medicines.
Shared decision making (SDM) is another approach that
has been advocated by the UK government over the years
[14] with the aim of encouraging patient involvement in
care decisions during consultations between patients and
HCPs to improve patients’ outcomes and quality of care
[15], and promote medicine optimisation [14]. SDM is a
fundamental component of patient-centred care [16]. The
latter has been demonstrated to be beneficial in terms of
improving patients’ outcomes, satisfaction, adherence to
medications and disease burden [16–22].
This study aimed: first, to investigate hospital patients’
receipt and involvement in medication counselling, pa-
tients’ HCP preference for receiving medication informa-
tion at the transition of care, and awareness of community
pharmacy services such as the MUR. Second, to explore
perceptions and experiences of patients with LTCs about
the quality of care received in primary care and their aware-
ness of the MUR service provided in the community phar-
macy sector, focusing on COPD patients as an example.
Methods
This is a mixed method research study involving quantita-
tive cross-sectional surveys and qualitative semi-structured
interviews with patients across South West London.
The quantitative phase: Survey with patients
This phase was undertaken to address the first aim of this
study and involved two cross-sectional surveys at two
large South West London teaching hospitals: St George’s
Hospital (6 wards) and Croydon University Hospital (2
wards). The two surveys were conducted sequentially in
each hospital. For each survey, data was collected over
4 weeks at a rate of two days per week for each ward. Data
collection started at St George’s Hospital, 6 medical wards
were targeted and data collection took over 4 weeks for
each ward. Once survey one was completed, data collec-
tion started for survey 2 using the same strategy. Thus
data collection took 6 months for each survey, a total of
one year for both surveys from December 2013 till
December 2014. For survey one, screening of drug charts
was also performed for each patient who completed the
survey. This was conducted by the researcher pharmacists
to check whether any new medication was added or any
changes in drug dose, strength or formulation was made
in relation to the main LTC they suffer from.
At the start of February 2015, data collection com-
menced at Croydon University Hospital for 2 medical
wards and took over 4 months using the same strategy
and was completed end of June 2015.
The first survey (see Additional file 1) was conducted
among 357 patients at both hospitals and covered two
areas: knowledge/experience/opinion of SDM and the
patient’s involvement in decisions made about changes
to their medication. The second survey was conducted
among 240 patients at both hospitals and measured
medication counselling received whilst in hospital and
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patient interest in receiving medication services after
discharge from community pharmacies.
As this was a service evaluation, a purposive sampling
strategy was used to recruit patients. For both surveys,
patients were considered for inclusion if they were: ≥
18 years, suffering from a LTC including: diabetes, COPD/
Asthma or cardiac condition which was controlled by
medication. Patients also needed to have a level of English
to enable them to understand and complete the question-
naire and be capable of giving written consent to partici-
pate. An additional inclusion criterion for survey 2 was
patients due to be discharged from the hospital. Patients
were excluded if they were: < 18 years, unable to under-
stand written or spoken English, with cognitive impairment,
and those unwilling to participate. Sample size calculation
was performed using the Raosoft sample size calculator
providing a confidence level of 95% with margin of error of
5% and based on the approximate number of inpatient beds
in both hospitals. St’ Georges hospital has 1300 inpatient
beds and Croydon University Hospital has 565 inpatient
beds. Therefore, the total sample size was 319 for each sur-
vey at 95% confidence level and 5% margin of error.
For both surveys, each patient was invited by one re-
searcher to participate in a structured interview using a
questionnaire. Patients were given a detailed informa-
tion sheet about the study to read and consider before
participation.
After ethical approval and prior to data collection, pilot
studies were conducted to validate the two surveys involv-
ing 35 and 14 patients, respectively.
Data analysis
All responses to both questionnaires were coded and en-
tered into Microsoft excel spreadsheets and then analysed
using Microsoft Excel as well. Simple descriptive statistics
was used to summarise the demographic characteristics of
the participants and the generated findings and valid per-
centages were reported.
The qualitative phase: Semi-structured interviews with
patients
This phase was undertaken to address the second aim of
this study. A purposive sampling strategy was used to
recruit participants, by approaching patients attending
the respiratory HoT clinic at Croydon University Hospital.
This strategy was employed to ensure the feasibility and
convenience of face-to-face interviews with patients. Pa-
tients were approached in person by two researchers (NA,
MAU) at the respiratory HoT clinic and provided with a
detailed information sheet about the study to read and
consider. Patients were included in the study if they: have
been diagnosed with COPD for at least one year, and on
current COPD medications. Patients unable to speak or
understand English were excluded. Patients who met the
inclusion criteria and accepted to participate were in-
cluded. The interview schedule (See Additional file 2) was
designed by the authors and included 23 open and closed
ended questions that were divided to cover the following
areas: demographics, disease knowledge, decision making
and counselling, use of Patient information Leaflet (PIL),
and awareness and experience of the MUR service.
Sample size was guided by the concept of data satur-
ation [23, 24], which refers to the point where no new in-
formation is emerging out of the interviews and hence the
collection of new information does not yield any further
exploration of the issue under investigation [24]. Based on
a stopping criterion of 3 consecutive interviews with no
new information [23], data saturation was achieved at the
15th interview. However, all interviews were included for
analysis.
The interviews were carried out in the respiratory
HoT clinic between January and March 2016 by two re-
searchers (NA, MAU). Permission was granted from the
specialized respiratory team running the respiratory
HoT clinic to conduct the interviews at the premises. Pa-
tients were required to sign a written consent form for
conducting and recording the interviews. Each interview
took an average of 15 min to conduct. All interviews
were audio recorded and transcribed verbatim for subse-
quent analysis.
Data analysis
Thematic analysis adopting inductive/deductive approaches
was used to identify key themes. The transcripts were read
and re-read several times to achieve familiarization with the
data, then coded manually and independently by the two
researchers who conducted the interviews and a third
researcher (IH) to enhance analytical rigor. The codes were
then checked, discussed and confirmed by three other
researchers (RK, IH and SNG) involved in the study and
experienced in conducting qualitative research. Results are
presented in form for themes and associated subthemes.
Participants’ quotations are presented within the emergent
themes and subthemes to illustrate the findings.
Ethical consideration
Ethical approval for the quantitative and qualitative phases
was granted by the Kingston University Delegated Research
Ethics Committee (Ref: 1213/045). Both Croydon University
Hospital and St. George’s Hospital considered the study as
service evaluation and approved it as such.
Results
Cross-sectional survey with patients
Two short surveys were carried out at St. George’s Hospital
and Croydon University Hospital. Four hundred and fifty
patients were approached for the first survey and 357 pa-
tients agreed to participate, giving a response rate of 79.3%.
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Whereas for survey 2, 350 patients were approached and
240 patients agreed to participate, giving a response rate of
68.5%. Over 60% of patients and over a third of patients
were ≥ 60 years old in survey 1 and survey 2 respectively.
Diabetes, respiratory and cardiac conditions were the most
commonly specified LTCs in both surveys (Table 1).
Survey 1
It was noted from screening the hospital medication
charts that nearly three-quarters of patients (71.1%, n =
254/357) had additions or changes made to their pre-
scribed medications for the main LTC they suffer from
while in hospital. However, only two-thirds of patients
(66.9%, n = 170/254) were aware of these changes and only
40% (n = 68/170) were consulted about these changes. But
it was found that 62.2% (n = 158/254) of patients wanted
to be involved in the decisions about their treatment. The
reasons patients gave for not wanting to be involved in-
cluded “Doctor knows best” (n = 17), “Trust in the doctor”
(n = 41), or expressing the feeling that the doctor is the
“expert” (n = 8), did not know much about their condition
and medication to take decisions (n = 17) and fear of
learning about their condition (n = 5). The remaining eight
patients did not provide any reasons.
Survey 2
When asked about medication counselling received, all 240
patients said they had received medication counselling. The
specific information received during the counseling were
related to the following in order of frequency; how to take
the medication, purpose of the medication, important
side-effects action to take in case of having important
side-effects, with lifestyle changes having the lowest fre-
quency (Table 2). A third of patients thought that coun-
selling could be improved, with an increased amount of
time being the most common suggestion (Table 2).
The majority of patients were not aware of community
pharmacy services; NMS (93%) or MUR (83%). However,
once they were informed and briefed about the NMS
and MUR services by the researchers, they were interested
in receiving these services (84%) and (88.8%) respectively.
When patients were asked where would they go if they
encountered medication difficulties post-discharge, a mix-
ture of responses was given (Table 2) with nearly a third
indicating contacting a general practitioner (GP), followed
Table 1 Socio-demographic data
Socio-demographic Data n (%)
Gender Survey 1 (N = 357) Survey 2 (N = 240)
Female n = 133 (37.3%) n = 100 (41.7%)
Male n = 224 (62.8%) n = 140 (58.3%)
Age
18–30 n = 4 (1.1%) n = 39 (16.3%)
31–45 n = 7 (2.0%) n = 17 (7.1%)
46–59 n = 36 (10.1%) n = 98 (40.1%)
≥ 60 n = 221(61.9%) n = 86 (35.8%)
Prefer not to say n = 89 (24.9%) n = 0 (0%)
Main chronic condition
COPD n = 53 (14.8%) n = 36 (15%)
Asthma n = 45 (12.6%) n = 28 (11.7%)
Hypertension n = 66 (18.5%) n = 40 (16.7%)
Cardiac condition n = 114 (31.9%) n = 70 (29.2%)
Diabetes Mellitus Types 1 & 2 n = 67 (18.8%) n = 38 (15.8%)
Rheumatoid arthritis and
osteoarthritis
n = 0 (0%) n = 20 (8.3%)
Other LTCs, e.g.: epilepsy,
chronic renal disease,
inflammatory bowel disease
n = 12 (3.4%) n = 8 (3.3%)
Table 2 Participants’ experience with medication counselling
Experience with medication counselling
Number Percentage (%)
Topics covered during medication counselling (N = 240)
Purpose of the medication 239 99.5
How to take the medication 240 100
Important side-effects 92 38.3
Action to take in case of having important
side-effects
42 17.5
Lifestyle changes 34 14.1
Suggestions for improvement of medication counselling (N = 90)
Provision of more time 40 44.5
Change of staff 24 26.7
Amount of information provided 17 18.8
Straight forward/easy language 10 11.1
Privacy 10 11.1
Provision of medication counselling by community pharmacists after
discharge (N = 240)
Yes 86 35.8
No 127 52.9
Unsure 26 10.8
Provision of discharge medications from community pharmacists (N = 240)
Yes 139 57.9
No 77 32.1
Unsure 24 10
Preferred sources of information if patient encountered a problem with
a medication post-discharge (N = 240)
GP 80 33.34
Community pharmacist 61 25.42
Patient information leaflet 58 24.16
Internet 38 15.83
Family and friends 3 1.25
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by a quarter for either contacting a community pharma-
cist, or reading the PIL. Other responses included search-
ing the internet and seeking help from friends and
relatives.
When patients were asked directly if they were inter-
ested in receiving medication counselling post-discharge
at their local pharmacy, a majority stated they were not
interested (Table 2). However, the majority of patients
were interested in receiving their discharge medications
from a community pharmacist rather than waiting for
them at the hospital (Table 2).
Semi-structured interviews with patients
Face-to-face semi-structured interviews were performed
with 18 COPD patients; 11 females and 7 males (Table 3).
Analysis of the patients’ interviews revealed three main
themes:
1- Lack of patient-centered care and shared decision
making
Some patients expressed their frustrations as they felt
that not enough attention was provided by the HCP to
the specific details of their symptoms and how they were
feeling in general when they were initially diagnosed, as
highlighted in the below quotes:
“I want to be treated for me, not a number in a box.”
[Patient 14]
“It looked like they didn’t really pay much attention to
how I really felt and instead went about it their own
way.” [Patient 11]
Furthermore, some participants were overwhelmed when
they were first diagnosed, and this affected their ability to
retain any information regarding the disease.
“When I was first diagnosed with COPD I was kind of
overwhelmed and stressed so most I didn’t recall
everything said by the doctor so emm…I don’t remember
if anything was said about the disease.” [Patient 1]
In fact, all participants lacked detailed knowledge about
the aetiology of the disease, but reported their awareness
of smoking being the main cause of COPD.
“Nothing was said at the beginning but I know
smoking is the cause for this disease.” [Patient 2]
“Me and my wife were not told much about the
disease so we had to do our own research.” [Patient 4]
Analysis of the interviews also revealed that most
patients (n = 16/18) were not simply involved in any
decision making regarding the prescription of their re-
spiratory medications.
“No one asked for my opinion on anything [coughing]”
[Patient 2]
“There was not really any chance for me to have any
say when it came to my treatment” [Patient 14]
Furthermore, the analysis highlighted that some patients
(n = 6/18) did not want to be involved in any decisions re-
garding change to their medications as they completely
rely on their doctor’s advice. Others (n = 8/18) felt that
whatever decisions their prescriber makes, they trust them
and so didn’t feel the need to try and be involved as well.
“I don’t think I needed to be involved anyway as I
already trusted what they were doing.” [Patient 17]
“Was not involved at all. To be honest, I only want the
doctor suggestions…don’t trust myself.” [Patient 3]
“No involvement at all…. I prefer to rely on what the
doctor decides for me.” [Patient 7]
2- Minimal counselling provided by HCPs
Most of the patients (n = 14) reported that counselling
and advice covered the basics such as when to take or
how to take their inhalers. They felt that it was brief and
that more could have been done or provided to make
them fully confident about using their medicines.
“Counselling only involved basic use of the inhalers,
lasted for a few seconds.” [Patient 6]
The rest (n = 4) indicated receiving no counselling
when their medications were first provided.
“I was told nothing after I received my medicines”.
[Patient 12]
Patients who received counselling reported having such
counselling either from the GP or community pharmacist;
Table 3 Characteristics of patients included for the interviews
Patients characteristics Number of participants (out of n = 18)
Age group 55–65 years 5
Over 65 years 13
Gender Male 7
Female 11
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leaflets were the main source of information that was
given to them.
“I was simply advised to read up in the information
leaflet in order to know about my medicines” [Patient 14]
Interestingly, most patients reported using the PIL pro-
vided with the medication before taking it. Patients re-
ported reading the PIL to enquire more about several
issues related to their medications such as: how to take/
use the medicine, side effects, alcohol intake while taking
their medication and check if the medicine affects driving.
“I always make sure to have a proper look at the
leaflet for anything I need to be aware of.” [Patient 18]
3- Limited awareness about the MUR service
Only 5 patients were aware about the MUR service
that is provided by the community pharmacist, and only
3 of them undertook the review with the community
pharmacist. Therefore, the majority of the patients were
not aware of the service and required explanation about
the service. Even after providing an explanation to them,
they said that they were not aware of the service and its
existence at their local pharmacy.
“No, I’ve never heard about it.” [Patient 1]
“I never knew this service was available, nobody told
me about it.” [Patient 12]
Discussion
The current study sheds light on several issues related to
patients’ perceptions regarding counselling about medi-
cations and SDM and their awareness of community
pharmacy services that could enhance understanding of
their medications and conditions. The generated results
clearly identified that there is a lack of detailed medication
counselling and patients’ involvement in SDM, which echo
previous findings in the literature [5, 25]. Underutilisation
of community pharmacy services was also highlighted in
this study by the lack of awareness among target patients
about services related to medication optimisation and
counselling which can be promptly and easily accessible
at primary care level. A new finding revealed in this
study was patients’ preference for receiving their dis-
charge medications from community pharmacies. This
could provide a solution for the delay in discharge related
to the long wait for discharge medications highlighted in
the literature [25].
This study highlighted problematic issues related to
counselling in both primary care and during transition
of care. Despite the fact that all patients have received
medication counselling upon discharge, yet all consulta-
tions only covered basic topics mainly the purpose of the
medication and how to take it, whereas other important
topics related to side effects and life style changes were only
covered in less than 40% of these consultations. More than
30% of patients who participated in the second survey
thought that medication counselling could be improved
prior to hospital discharge. Interestingly, in previous re-
search, patient counselling was perceived by HCPs to
be limited at hospital discharge in England [5]. Counsel-
ling was also perceived by the interviewees to be basic,
brief and minimal. Patients expressed their need for more
detailed counselling during the interviews. Not surpris-
ingly, this study found that a quarter of the surveyed pa-
tients would refer to the PIL if encountered problems
with a medication post-discharge. This was echoed by the
interview results where interviewees reported the use of
the PIL to seek additional medication information, which
can be related to the minimal counselling reported by
these patients. In previous research, the main reason cited
by patients for not reading PILs was the provision of pre-
vious effective counselling by HCPs [26].
The need for better education about COPD as a disease
among patients has been previously raised in the literature
[8, 27, 28] to improve patients’ quality of life [8]. Despite
that patient education has been acknowledged as pivotal
to the care of COPD patients and a cornerstone to the
management of the disease [8, 27, 29], yet the current
study still highlights basic knowledge about the disease.
This indicates that nothing has changed with respect to
patient education, despite the latter being reported as poor
among COPD patients in the literature for more than
10 years [30].
The results of the first survey showed that although
70% of patients had changes made to their medications,
only a third was consulted about the changes. The same
was echoed in our interviews, which denotes a paternalistic
model of care rather than SDM. In addition, the inter-
viewees highlighted lack of personalised care by HCPs. This
finding is of concern, given the increased advocacy in the
National Health Service (NHS) in England towards the im-
plementation of patient-centred care which involves SDM
[31]. Previous studies in England highlighted lack of patient
involvement throughout the discharge process [5, 25] and
primary care consultations [32]. For over 25 years, NHS
directives have recommended increasing patients’ involve-
ment in their care decisions [33]. This was encouraged
from the 1990’s [33–35] and in 2012 the phrase “No deci-
sion about me, without me” [36] was devised to advertise
the NHS commitment to SDM, so that this becomes the
norm practice across the NHS [25, 36]. Yet, the current
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results show that SDM is still not widely implemented dur-
ing consultations with patients.
Additionally, more than two-thirds of patients at the
two hospitals wanted to be involved in decisions about
their medications. Patients who did not want to be in-
volved in their treatment expressed trust in the doctors’
decision; this confidence in doctors was shown again by
patients’ HCP preference for receiving medical informa-
tion. However, this was different in our interviews, as
most of the interviewees were not willing to be involved
in decisions about their care. What was clear from the
interviews is that some patients did not want to be involved
in their care, whereas others did not perceive such involve-
ment to be important. However, patients’ preferences for
participation in decision making can vary substantially,
hence patients can either adopt a passive role or an active/
collaborative role in making decisions about their health
[37, 38]. Research conducted in the USA, showed that al-
though patients described participation in decision making,
yet many deferred the final decision to their doctors [39].
Another study in England showed that one third of the
patients preferred the doctors to make decisions for them
[40]. However, provision of patient-centred care involving
SDM necessitates different HCP skills, maintaining patient
trust, and the provision of detailed counselling including
evidence-based information about options, outcomes and
uncertainties, together with decision-support counselling
[41, 42]. Hence, the provision of brief and minimal counsel-
ling reported in this study provides a potential explanation
to the reported lack of personalised care and SDM experi-
enced by the interviewees. Another possible explanation
would be age; most of the interviewees in the current study
were over 65; which was reported in the literature to affect
patients’ preferences for SDM [15, 43], with older patients
preferring to be less active in medical decision making dur-
ing consultations in primary care [15]. Despite age being
also cited as a reason for patients being passive in decisions
about care during the hospital discharge process [44], yet
most patients at the two hospitals, despite being elderly,
wanted to be involved in decisions. Interestingly, this high-
lights a difference for SDM preference which can be related
to the healthcare setting in this study. In the hospital setting
and specifically during hospital discharge which is a com-
plex and lengthy process [25], SDM was more preferred
than in the respiratory HoT clinic setting which was devel-
oped in Croydon to provide a smooth and rapid service in
the community to high-risk patients. In fact, patient in-
volvement is a complex and multifactorial issue which can
be affected by patient, doctor and contextual factors such
as clinical settings [45]. This in return re-emphasises the
need for HCPs to adopt interventions to promote patient
participation including elderly through creating a trusting
environment during the consultation that allow patients to
feel comfortable speaking up and asking questions about
their care [15], given the increased prevalence of elderly
people with LTCs [14]. In one study, the doctor’s communi-
cative style was found to be one of the strongest predictors
of patient involvement in care [45].
Despite the MUR service being introduced in England
in 2005, the current findings still highlight a considerable
lack of awareness of the service among participants in
both phases of the study. This finding is of also of concern
due to several reasons. First, the MUR service has been
introduced for more than 10 years in the community
pharmacy sector in England. Second, community pharma-
cies in England are expected to perform at least 70% of
MURs with patients falling within the agreed national
target groups since April 2015 [46]. Post-discharge and re-
spiratory patients having COPD are among the national
target groups for this service [46]. Research evidence from
several countries demonstrated low awareness of medicine
related cognitive services offered by community phar-
macists among the public [11]. A survey study in 2012
among the public and community pharmacists in England
reported low awareness of the MUR service among the
public, even in regular medicines users [11]. The latter
study also highlighted how community pharmacists over-
estimated patients’ awareness of the MUR service, in con-
trast to the actual awareness reported in the study which
was indeed low [11]. The current results also show a re-
markable low level of awareness among patients who are
the target groups for this service. This indicates that noth-
ing has changed to promote patients’ awareness about
services that are easily accessible and essential to patients
with LTCs such as the MUR service in the community
pharmacies in England. This also places a great emphasis
on the importance and need among all HCPs, whether in
primary or secondary care to promote awareness especially
among target patients about the MUR service in England.
It also aligns with the call raised by the Royal Pharmaceut-
ical Society in the UK for greater public awareness of phar-
macy services [47]. In the current study, patients at both
hospitals wanted to participate in MUR and NMS services
once informed about them. However, a study in England
highlighted that few hospitals refer patients after discharge
to community pharmacies for MUR or NMS as currently
recommended [5], the research also highlighted the lack of
communications between HCPs in secondary care with
HCPs in primary care especially community pharmacists.
In addition, existing evidence suggests that patients still
consider GPs as their main source of information about
their medications after discharge, which might be due lack
of awareness about the MUR and NMS services at the
community [25], hence patients can be more willing to
participate in these services if they are signposted by their
GPs [13]. Patients at the two hospitals also wanted to re-
ceive their discharge medications from community phar-
macists, possibly due to the long waiting times in hospitals.
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In a previous research in the UK, waiting for medicines
was the most commonly perceived reason for delays in
hospital discharges [25]. A transfer of the provision of dis-
charge as well as of out-patient medications from hospital
to local community pharmacies, as proposed in the Carter
report [48] would enable patients to receive their medica-
tions and additionally NMS and MUR at a more conveni-
ent location and time. This also coincides with the calls to
provide a new model of care for patient discharge which
involves support with medicines after discharge by com-
munity pharmacists [25].
The current study has several limitations including the
small sample size and the use of purposive sampling within
an urban community in London borough of Croydon for
the qualitative phase. Interviews were sought among pa-
tients with one LTC which is COPD; hence the results may
not be reflective of the views of patients with other LTCs.
Patients with COPD were chosen for this phase for three
main reasons. First, the convenience of recruitment to the
researchers within the respiratory HoT clinic at Croydon
University Hospital. Second, COPD patients are a target
group for MUR and NMS services offered in community
pharmacies. Third, the high economic burden associated
with COPD treatment with respect to exacerbations and
hospital admissions.
In addition, as patients were in acute setting, the data
collection tool for the quantitative phase had to be con-
cise, hence the topics evaluated had to be split into two
surveys. Even though minor amendments were required
with the surveys, yet the pilot surveys were not included
in the final analysis to avoid any type of bias. The sample
size required for survey 2 was not achieved despite ap-
proaching 350 patients; this could be due to the fact that
the survey was done among patients ready to be discharged
from the hospital so this may have impacted their willing-
ness to complete the survey in order to avoid delays in leav-
ing the hospital. Another limitation is that population age
in the two surveys was different; as older patients were
more prevalent in the first survey, whereas younger patients
were over presented in the second survey.
Conclusion
A significant number of patients are still not involved in
discussions about changes to their medication/treatment
despite many NHS recommendations to move from a
paternalistic approach to a shared decision model. Des-
pite the huge cost associated with the poor management
of COPD and patients post-discharge, and the fact that
SDM could support patients’ management in relation
to medicine optimisation, exacerbations and hospital
admissions/re-admissions, the principle is not widely
implemented. There was also a remarkable low level of
awareness of the MUR service among post-discharge
and respiratory patients who are target groups for this
service. The current results emphasise the need among
HCPs in primary and secondary care to promote awareness
among patients about services targeting medicine optimisa-
tion, regardless when these services were introduced, in
order to enhance care experienced by patients with LTCs.
It also reinforces the need among HCPs in primary and
secondary care to promote patient-centred approach during
consultations to enhance SDM. This study is limited to two
hospital settings in Greater London, a similar study on a
national scale is recommended to further investigate pa-
tients’ preference for receiving discharge medications from
community pharmacies among larger population and inves-
tigate the feasibility of such a new model of post-discharge
service provision to enhance the quality of care in the
future. Nevertheless, using community pharmacy services
for medication supply and counselling post discharge could
provide a solution to the pressure experienced by acute
NHS hospitals [49] and hence increase their operational
productivity and performance in the future, and comes
in line with the government’s health policy “Better care
Fund” to rely more on community-based services in the
future [49, 50].
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